AACR members at the AACR Annual Meeting 2023. The AACR’s mission to prevent and cure all cancers is driven by its members. AACR member scientists, clinicians, and other health care professionals around the world foster discovery and innovation across the entire spectrum of cancer science. AACR programs and initiatives forge connection and communication among these members, aligning their efforts and catalyzing progress for cancer patients. Active Members: Established laboratory researchers, physician-scient

Hope S. Rugo, MD, presents the results of the phase II KEYLYNK-009 study during the General Session at the San Antonio Breast Cancer Symposium in December. The AACR partners with UT Health San Antonio to develop the program for the Symposium. The AACR uses the power of collaboration to lead progress against cancer, convening key stakeholders from across the cancer research community and fostering the relationships needed to devel op bold solutions to the most challenging aspects of the cancer problem. In

Brian Beck was diagnosed with stage IV colon cancer at age 54. In January 2023, when his cancer recurred after several initial treatments, he enrolled in a clinical trial testing a combination of two HER2-targeted therapies, tucatinib and trastuzumab, which has kept his cancer in check. Two weeks after he enrolled in the trial, the therapy was approved by the FDA. He shared his story in the AACR Cancer Progress Report 2023. We are in an era of extraordinary scientific progress against cancer. Breakthrough

AACR Chief Executive Officer Margaret Foti, PhD, MD (hc), outlines the AACR’s efforts to advance cancer health equity during the Opening Ceremony at the AACR Annual Meeting 2023. As an organization whose core values include diversity, equity, and inclusion, the AACR is deeply committed to achieving the bold vision of cancer health equity for all. The AACR leads the cancer research community in the pursuit of this vision in three ways: by eliminating cancer health disparities; by ensuring that everyone can